Genetically Engineered Lymphocyte Therapy in Treating Patients With B-Cell Leukemia or Lymphoma That is Resistant or Refractory to Chemotherapy

Clinical Trial ID NCT01029366

PubWeight™ 69.61‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01029366

Top papers

Rank Title Journal Year PubWeight™‹?›
Next 100